News
TELA
0.9600
-5.88%
-0.0600
Tela Bio Earnings Call Balances Momentum and Risk
TipRanks · 16h ago
Lake Street Keeps Their Buy Rating on TELA Bio (TELA)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)
TipRanks · 1d ago
Analysts Conflicted on These Healthcare Names: TELA Bio (TELA), Rezolute (RZLT) and Legend Biotech (LEGN)
TipRanks · 1d ago
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M
Seeking Alpha · 1d ago
TELA Bio Q1 2026 Earnings Call Transcript
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 1d ago
TELA Bio posts modest Q1 growth, maintains 2026 outlook
TipRanks · 1d ago
TELA Bio GAAP EPS of -$0.21 misses by $0.02, revenue of $19.1M beats by $0.1M
Seeking Alpha · 1d ago
TELA Bio Q1 revenue growth beats estimates, loss widens
Reuters · 1d ago
*TELA Bio Sees 2Q Rev $20M >TELA
Dow Jones · 1d ago
*TELA Bio Backs FY26 Revenue Guidance of at Least 8% Growth Over FY25 >TELA
Dow Jones · 1d ago
TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M Est
Benzinga · 1d ago
TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate
Benzinga · 1d ago
*TELA Bio 1Q Loss $12.3M >TELA
Dow Jones · 1d ago
*TELA Bio 1Q Rev $19.1M >TELA
Dow Jones · 1d ago
Press Release: TELA Bio Reports First Quarter 2026 Financial Results
Dow Jones · 1d ago
*TELA Bio 1Q Loss/Shr 21c >TELA
Dow Jones · 1d ago
Earnings Scheduled For May 12, 2026
Benzinga · 2d ago
Weekly Report: what happened at TELA last week (0504-0508)?
Weekly Report · 3d ago
More
Webull provides a variety of real-time TELA stock news. You can receive the latest news about Tela Bio, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TELA
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.